Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Multicenter Study Lasting 12 Months to Determine the Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia Major and Intermedia and Verify the Suitability of Common Diagnostic Criteria in This Population

NCT01496963 is registered in ClinicalTrials.gov with Ente Ospedaliero Ospedali Galliera as lead sponsor.

NCT NCT01496963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01496963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Multicenter Study Lasting 12 Months to Determine the Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia Major and Intermedia and Verify the Suitability of Common Diagnostic Criteria in This Population
Lead sponsor
Ente Ospedaliero Ospedali Galliera
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
December 31, 2021
Enrollment
1,500 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, thalassemia intermedia, thalassemia major